Clinical utility of circulating tumour cell detection in non-small-cell lung cancer

Current Treatment Options in Oncology

Volumn 14, Issue 4, 2013, Pages 610-622

  Fusi, Alberto ^a   Metcalf, Robert ^a,b   Krebs, Matthew ^a,b   Dive, Caroline ^b   Blackhall, Fiona ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biomarkers; Circulating tumour cells; NSCLC; Review

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ALK GENE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL ASSAY; CELL ISOLATION; CELL SIZE; CIRCULATING TUMOR CELL; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MUTATIONAL ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84890801827     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-013-0253-5     Document Type: Review

References (33)

1. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-73.
2. Meropol NJ, Cohen SJ, Iannotti N, et al. Circulating tumour cells (CTC) predict progression free (PFS) and overall survival (OS) in patients with metastatic colorectal cancer. J Clin Oncol. 2007;25:4010-6.
3. Danila DC, Heller G, Gignac GA, et al. Circulating tumour cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res. 2007;13:7053-8.
4. Pachmann K, Camara O, Kavallaris, et al. Monitoring the response of circulating epithelial tumour cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol. 2008;26:1208-15.
5. Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumour cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23:1420-30.
6. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumour cells to tumour response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol; 26:3213-3221.
7. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumour cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781-91.
8. de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumour cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14:6302-9.
9. Yamashita J, Matsuo A, Kurusu Y, et al. Preoperative evidence of circulating tumour cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg. 2002;124:299-305.
10. Sher YP, Shih JY, Yang PC, et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res. 2005;11:173-9.
11. Chen TF, Jiang GL, Fu XL, et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer. 2007;56:105-14.
12. Liu L, Liao GQ, He P, et al. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun. 2008;372:756-60.
13. Yie S, Lou B, Ye S, et al. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer. 2009;63:284-90.
14. Yoon SO, Kim YT, Jung KC, et al. TTF-1 mRNA-positive circulating tumour cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer. 2011;71:209-16.
15. Liu Z, Fusi A, Klopocki E, et al. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumour cells from peripheral blood of cancer patients. J Transl Med. 2011;9:70.
16. •• Allard WJ, Matera J, Miller MC, et al. Tumour cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897-904. This is the first large study to evaluate systematically the accuracy and reproducibility of the CellSearch system. The prevalence of CTCs in 964 patients with metastatic carcinomas also was assessed.
17. Riethdorf S, Fritsche H, Müller W, et al. Detection of circulating tumour cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Seach system. Clin Cancer Res. 2007;13:920-8.
18. Talasaz AH, Powell AA, Huber DE, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci USA. 2009;106:3970-5.
19. Cann GM, Gulzar ZG, Cooper S, et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One. 2012;7:e49144.
20. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450:1235-9.
21. Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumour cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A. 2010;107:1832-7.
22. Ozkumur E, Shah AM, Ciciliano JC, et al. Inertial focusing for tumour antigen-dependent and -independent sorting of rare circulating tumour cells. Sci Transl Med. 2013;5:179ra47.
23. Hofman V, Bonnetaud C, Ilie MI, et al. Preoperative circulating tumour cell detection using the isolation by size of epithelial tumour cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res. 2011;17:827-35.
24. Hofman V, Ilie MI, Long E, et al. Detection of circulating tumour cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the Cell Search Assay™ and the isolation by size of epithelial tumour cell method. Int J Cancer. 2011;129:1651-60.
25. Hou JM, Krebs M, Ward T, et al. Circulating tumour cells as a window on metastasis biology in lung cancer. Am J Pathol. 2011;178:989-96.
26. •• Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumour cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011;29:1556-63. This study showed CellSearch detected CTCs as an adverse prognostic factor in stage III-IV NSCLC. PFS and OS were significantly shorter in patients with ≥5 CTCs per 7.5 ml of blood. CTCs were an independent worse prognostic factor for PFS and OS in the multivariate analysis.
27. •• Punnoose EA, Atwal S, Liu W, et al. Evaluation of circulating tumour cells and circulating tumour DNA in non-small cell lung cancer: association with clinical endpoints in a Phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res. 2012;18:2391-401. This study analysed CTCs for EGFR expression and for mutational status of a panel of genes. EGFR protein expression in CTCs was heterogeneous not associated with response or expression at primary tumour. Detected mutations in CTCs were however concordant with mutational status in matched tumour.
28. •• Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med. 2008;359:366-77. This is the first study published that describes the potential of CTC genotypic characterization to predict tumour response and early resistance in NSCLC patients receiving EGFR-inhibitor.
29. Ilie M, Long E, Butori C, et al. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol. 2012;23:2907-13.
30. Pailler E, Adam J, Barthélémy A, et al. Detection of circulating tumour cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol. 2013;31:2273-81.
31. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363:1693-703.
32. Heitzer E, Auer M, Gasch C, et al. Complex tumour genomes inferred from single circulating tumour cells by Array-CGH and next-generation sequencing. Cancer Res. 2013;73:2965-75.
33. Powell AA, Talasaz AH, Zhang H, et al. Single cell profiling of circulating tumour cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One. 2012;7:e33788.